Pages that link to "Q72650895"

The following pages link to A Substance P Antagonist, [D-Pro 2 , D-Trp 7,9 ]SP, Inhibits Inflammatory Responses in the Rabbit Eye (Q72650895):

Displaying 45 items.

• Effect of infrared radiation on the lens. (Q33829572) (← links)
• Substance P, neurokinin A and neurokinin B in the ocular response to injury in the rabbit (Q35755877) (← links)
• Adenosine-modulation of cholinergic and non-adrenergic non-cholinergic neurotransmission in the rabbit iris sphincter (Q35887428) (← links)
• A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. (Q37604303) (← links)
• Neuropeptides in sensory neurons (Q40104070) (← links)
• Localization of Substance P in Neuronal Pathways (Q40104949) (← links)
• Substance P—A putative mediator of antidromic vasodilation (Q40105837) (← links)
• Parathyroid Hormone: Chemistry, Biosynthesis, and Mode of Action (Q40133727) (← links)
• Substance P (NK(1)) receptor expression by human colonic epithelial cell line Caco-2. (Q40697081) (← links)
• Effects of the substance P antagonist (D-Arg1, D-Pro2, D-Trp7, 9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine (Q41544441) (← links)
• Effects of spantide on guinea pig coronary resistance vessels (Q41769564) (← links)
• Role of nitric oxide (NO) in ocular inflammation (Q41851156) (← links)
• The contribution of nitric oxide to endotoxin-induced ocular inflammation: interaction with sensory nerve fibres (Q41852366) (← links)
• Inhibition of substance P release is the key to successful management of oral pain (Q41876690) (← links)
• The mechanism of action of a substance P antagonist (D-Pro2, D-Trp7,9)-SP. (Q41984028) (← links)
• In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid (Q42449177) (← links)
• Ocular inflammation induced by electroconvulsive treatment: contribution of nitric oxide and neuropeptides mobilized from C-fibres (Q43170552) (← links)
• Corticotropin-releasing factor inhibition of substance P-induced vascular leakage in rats: Possible sites of action (Q43512809) (← links)
• Species differences in the effects of substance P on inositol trisphosphate accumulation and cyclic AMP formation, and on contraction in isolated iris sphincter of the mammalian eye: Differences in receptor density (Q45220338) (← links)
• Synthesis and biological activities of neurokinin α and β (Q46169814) (← links)
• Substance P in the cerebral vasculature: depletion by capsaicin suggests a sensory role (Q46236168) (← links)
• Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea-pig (Q46987085) (← links)
• The neurobiology of vascular head pain (Q48641194) (← links)
• Substance P excitation of rat locus coeruleus neurones (Q48725541) (← links)
• Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins (Q50919872) (← links)
• In the eye (D-Pro2, D-Trp7,9)-SP is a substance P agonist, which modifies the responses to substance P, prostaglandin E1and antidromic trigeminal nerve stimulation (Q50931784) (← links)
• Pharmacological analysis of receptors involved in tachykininergic contraction induced by electrical transmural stimulation in the rabbit iris sphincter muscle (Q51660625) (← links)
• Ocular responses evoked by capsaicin and prostaglandin E2 are inhibited by a substance P antagonist (Q51851683) (← links)
• Bradykinin contracts the pupillary sphincter and evokes ocular inflammation through release of neuronal substance P (Q51852186) (← links)
• Systemic and intraocular uptake of spantide, a tachykinin antagonist, following topical application to the rabbit eye (Q52480158) (← links)
• Pharmacological characterization of four related substance P antagonist (Q53932155) (← links)
• Effects of substance P on inositol triphosphate accumulation, on contractile responses and on arachidonic acid release and prostaglandin biosynthesis in rabbit iris sphincter muscle. (Q64966287) (← links)
• In vivo pupillary constrictor effects of substance P in man (Q67691454) (← links)
• Elevated levels of substance P in intraocular fluid in proliferative vitreoretinopathy (Q67694043) (← links)
• Substance P-like immunoreactivity in the central retinal artery of the rabbit (Q69030203) (← links)
• Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone (Q69057168) (← links)
• In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P (Q69111371) (← links)
• Sympathectomy enhances the substance P-mediated breakdown of the blood-aqueous barrier in response to infrared irradiation of the rabbit iris (Q69382603) (← links)
• Corneal lesions induced by the systemic administration of capsaicin in neonatal mice and rats (Q70627045) (← links)
• Substance P-like immunoreactive nerves in the anterior segment of the rabbit, cat and monkey eye (Q72685008) (← links)
• A direct contact of substance P-containing nerve fibers with pupillary sphincter muscle of the rat: An immunohistochemical analysis (Q72687915) (← links)
• Specific Binding of a125I-Substance P Derivative to Rat Brain Synaptosomes (Q72692984) (← links)
• Substance P antagonists release histamine from peritoneal mast cells (Q72703968) (← links)
• Long-term administration of a substance P antagonist, (D-Pro2, D-Trp7,9)-SP, abolishes the response to ocular trauma (Q72730177) (← links)
• Ontogeny of substance p-containing structures in the ocular tissue of the rat: An immunohistochemical analysis (Q72732596) (← links)